COVID-19 drug trial halted: LAU-7b shows no clear benefit
Disease control
Terminated
This study tested an experimental drug called LAU-7b in adults hospitalized with COVID-19 who had higher risk of complications. The goal was to see if the drug could prevent respiratory failure or the need for a breathing machine. The trial was stopped early, and the results did …
Phase: PHASE2, PHASE3 • Sponsor: Laurent Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC